EA202191495A1 - COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY - Google Patents
COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITYInfo
- Publication number
- EA202191495A1 EA202191495A1 EA202191495A EA202191495A EA202191495A1 EA 202191495 A1 EA202191495 A1 EA 202191495A1 EA 202191495 A EA202191495 A EA 202191495A EA 202191495 A EA202191495 A EA 202191495A EA 202191495 A1 EA202191495 A1 EA 202191495A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- compositions
- arginase activity
- inhibiting arginase
- compounds
- Prior art date
Links
- 102000004452 Arginase Human genes 0.000 title abstract 3
- 108700024123 Arginases Proteins 0.000 title abstract 3
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к новому классу соединений, которые проявляют ингибирующую активность в отношении аргиназы, и к фармацевтическим композициям, содержащим соединения по изобретению. Также обеспечиваются способы лечения рака с помощью ингибиторов аргиназы в соответствии с изобретением.The invention relates to a new class of compounds that exhibit arginase inhibitory activity and to pharmaceutical compositions containing the compounds of the invention. Also provided are methods for treating cancer with arginase inhibitors in accordance with the invention.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662439614P | 2016-12-28 | 2016-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202191495A1 true EA202191495A1 (en) | 2021-09-13 |
Family
ID=69061839
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991517A EA038517B1 (en) | 2016-12-28 | 2017-12-22 | Compositions and methods for inhibiting arginase activity |
EA202191495A EA202191495A1 (en) | 2016-12-28 | 2017-12-22 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991517A EA038517B1 (en) | 2016-12-28 | 2017-12-22 | Compositions and methods for inhibiting arginase activity |
Country Status (1)
Country | Link |
---|---|
EA (2) | EA038517B1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140077963A (en) * | 2011-10-20 | 2014-06-24 | 글락소스미스클라인 엘엘씨 | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
-
2017
- 2017-12-22 EA EA201991517A patent/EA038517B1/en unknown
- 2017-12-22 EA EA202191495A patent/EA202191495A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201991517A1 (en) | 2019-12-30 |
EA038517B1 (en) | 2021-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020013649A (en) | Compositions and methods for inhibiting arginase activity. | |
EA201891057A1 (en) | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | |
EA202092590A1 (en) | PYRIDAZINONES AS PARP7 INHIBITORS | |
EA202091186A1 (en) | KRas G12C INHIBITORS | |
MX2018008052A (en) | Lsd1 inhibitors. | |
EA201692079A1 (en) | INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1 | |
EA201792205A1 (en) | HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS | |
EA201792186A1 (en) | INDOLAMIN-2,3-DIOXYGENASE INHIBITORS AND METHODS OF THEIR APPLICATION | |
EA201591599A1 (en) | IDO INHIBITORS | |
EA201690306A1 (en) | IDO INHIBITORS | |
EA201591823A1 (en) | IDO INHIBITORS | |
EA201690027A1 (en) | IDO INHIBITORS | |
EA201790170A1 (en) | THERAPEUTIC COMPOUNDS INHIBITORS | |
EA201690152A1 (en) | IDO INHIBITORS | |
EA201691134A1 (en) | NEW GLUTAMINASE INHIBITORS | |
MX2019007243A (en) | Ectonucleotidase inhibitors and methods of use thereof. | |
EA201692483A1 (en) | HYSTON METHYLASE INHIBITORS | |
EA201790082A1 (en) | INHIBITORS OF LYSINE-SPECIFIC DEMITILASE-1 | |
SA519410093B1 (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
EA201792580A1 (en) | IDO INHIBITORS | |
EA201791933A1 (en) | INHIBITION OF OLIG2 ACTIVITY | |
EA201890364A1 (en) | COMPOUNDS SUITABLE FOR INHIBITING ROR-GAMMA-t | |
EA201501187A1 (en) | NEW CHEMICAL COMPOUNDS (OPTIONS) AND THEIR APPLICATION FOR THE TREATMENT OF CANCER DISEASES | |
EA201990508A1 (en) | ACTIVITY INHIBITION Olig2 | |
EA201691896A1 (en) | CONNECTIONS AND METHODS OF THEIR APPLICATION |